
OMDA Stock Forecast & Price Target
OMDA Analyst Ratings
Bulls say
Omada Health is attractive because its B2B2C model through employers, health plans, and PBMs creates low customer-acquisition costs, recurring revenue, and high retention, with 90%+ customer retention and roughly 33% multi-product attach rates. The company also has a large and underpenetrated addressable market, supporting about 25M covered lives but only about 1.1M enrolled members, while GLP-1 demand, a 14% engagement lift for GLP-1 members, and 52% y/y GLP-1 billings growth reinforce near-term growth. Management’s raised long-term targets of 80% gross margin and 30% EBITDA margin, alongside a 20% revenue growth outlook and a 3x 2027 revenue valuation versus peers, suggest meaningful operating leverage and upside potential.
Bears say
Omada Health is facing a difficult competitive landscape, with benefit managers often favoring single-platform solutions yet point players and better-capitalized musculoskeletal rivals still threatening share, while regulatory burdens and virtual-only care limitations can slow adoption. Its revenue base also looks fragile because two Cigna-affiliated partners represented about 55% of 2024 revenue, making concentration risk material even though revenue rose 38% in FY24 and net revenue retention reached 128%. Although 1Q:26 showed operating expenses down about 5% year over year as a percent of revenue, long-term profitability still depends on sustained enrollment, clinical outcomes, and avoiding execution issues such as supplier disruption or cybersecurity breaches.
This aggregate rating is based on analysts' research of Omada Health Inc and is not a guaranteed prediction by Public.com or investment advice.
OMDA Analyst Forecast & Price Prediction
Start investing in OMDA
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Omada Health Inc (OMDA) Forecast
OMDA Analyst Forecast & Price Prediction
Start investing in OMDA
Order type
Buy in
Order amount
Est. shares
0 shares